StockNYSE · US · USDIndustrials · Specialty Business Services
$KODK
EASTMAN KODAK CO
Kodak is a manufacturer focused on commercial print, advanced materials and chemicals, headquartered in Rochester, New York. Its three reportable segments are Print, Advanced Materials and Chemicals, and Brand. Print sells digital offset plates and computer-to-plate systems, production presses, inks and other consumables, inkjet components, workflow software, services and toner-based digital printing solutions to commercial printers and industries including direct mail, publishing, newspapers, packaging and labels. Kodak earns recurring sales from consumables and equipment service, as well as from equipment and software sales. Advanced Materials and Chemicals offers photographic, industrial and motion picture films, specialty chemicals, coating services, pharmaceutical materials, functional printing products, analytical services and intellectual property licensing. Brand licenses the Kodak name for products including cameras, consumer printing and scanning devices, eyewear, batteries and apparel, earning royalties and upfront payments. The segment sells directly and through dealers, while brand licensees use their own distribution channels.
Eastman Kodak (KODK) director Philippe Katz bought 3,000 shares at $8.48, totaling $25.4K. His direct holdings increased to 190,026 shares. Katz also holds indirect positions through several entities, disclaiming beneficial ownership except for pecuniary interests.
EASTMAN KODAK CO (KODK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 30, 2026, the Compensation, Nominating and Governance Committee (the “Committee”) of the Board of Directors of E
via TradingView
KODK sentiment & insider activity
Over the past 7 days, AlphAI's AI scored 1 news story mentioning KODK (EASTMAN KODAK CO). Coverage has skewed bullish: 1 bullish, 0 neutral, and 0 bearish.
Recent KODK coverage spans financial news, earnings and insider activity.
In the last 30 days, KODK insiders filed 1 SEC Form 4 transaction — 1 purchase ($25K) and no sales. The most active reporter was Katz Philippe D with 1 filing.
What's driving KODK
Insider open-market buying can be read as modest bullish sentiment, but it is not a fundamental catalyst by itself.
Earnings call highlights point to improving liquidity and profitability, but continued pressure in the print business and ongoing balance-sheet de-risking.
AlphAI scores every news story that mentions KODK with an AI model for sentiment and relevance, and aggregates insider trades from EASTMAN KODAK CO's SEC EDGAR Form 4 filings. Figures refresh continuously.
Eastman Kodak (KODK) director Philippe Katz bought 3,000 shares at $8.48, totaling $25.4K. His direct holdings increased to 190,026 shares. Katz also holds indirect positions through several entities, disclaiming beneficial ownership except for pecuniary interests.
EASTMAN KODAK CO (KODK) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 30, 2026, the Compensation, Nominating and Governance Committee (the “Committee”) of the Board of Directors of E
Eastman Kodak (KODK) reported Q3 2026 earnings with $317M unrestricted cash, up $27M from June 2026. Operational EBITDA rose to $31M, up $2M YoY. Print revenue declined 7% due to material costs and competition. GAAP net income increased 62% to $21M. Debt reduced by $400M, including $101M in term loan repayments. Year-to-date revenue up 9% to $852M, with growth in all segments. AMC segment led with 21% growth. Gross profit rose 28% to $212M, and net income improved $42M YoY.
Kodak (KODK) reported Q3 2026 earnings with 3% revenue growth to $276M, improved profitability, and significant debt reduction. Cash generation increased to $27M, and total debt decreased by $397M. Despite progress, shares fell 6.11% in after-hours trading to $8.14.
Kodak (KODK) added KODAK Normal Saline, 0.9% to its pharmaceutical line and launched a U.S. online store for direct purchases. The solution is FDA-registered and USP-compliant, targeting lab and bioprocessing workflows. Kodak plans to expand its pharmaceutical portfolio, including Class II products. The company markets its solutions as sterile, traceable, and domestically produced.
Eastman Kodak (KODK) reported 18% YOY revenue growth to $311M, with print and advanced materials segments up 10% and 40% respectively. Gross margin improved 700 bps to 26%, and operational EBITDA grew to $36M. The company is exploring new markets like EV batteries and pharma reagents. NeurAxis (NRXS) also shows potential with high gross margins and product traction.
Dupli, a UK-based company, has been appointed as the official distributor for Eastman Kodak Film, aiming to improve supply and pricing consistency for retailers and photographers. The move is part of Dupli's broader expansion in the analogue photography market, which includes other brands like CineStill and Ilford. The specific Kodak film stocks to be distributed have not yet been disclosed.
Eastman Kodak Co. (KODK) shares fell 4.54% to $9.04 on Friday, marking a second straight day of declines. The NASDAQ and Dow Jones also dropped, by 0.52% and 0.02% respectively.
Eastman Kodak (KODK) has partnered with UK-based Dupli to distribute its rebranded films in the UK. Dupli will offer Kodak's 35mm, 120, and large-format films. Kodak previously sold its marketing division but has since regained control of distribution.